Literature DB >> 8992921

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization.

M A Birdsall1, C M Farquhar, H D White.   

Abstract

BACKGROUND: Women with polycystic ovaries have associated risk factors for coronary artery disease. It is unknown whether women with more extensive coronary artery disease are more likely to have polycystic ovaries.
OBJECTIVE: To determine whether women who have more extensive coronary artery disease as seen on coronary angiography are more likely to have polycystic ovaries appearing on ultrasonography than are women with less severe coronary disease.
DESIGN: Prevalence study of women who had had coronary angiography.
SETTING: Women referred for coronary angiography for assessment of chest pain or valvular disease in Auckland, New Zealand, during a 2-year period. PATIENTS: 143 women 60 years of age or younger who had had coronary angiography. Women who had previously had bilateral oophorectomy were excluded. MEASUREMENTS: The extent of coronary artery disease assessed by quantitative angiography was compared with the presence or absence of polycystic ovaries. Pelvic ultrasonography was done without knowledge of the extent of coronary artery disease. Assessment of angiograms was blinded. Insulin resistance and gonadotropin, testosterone, and serum lipid levels were also measured.
RESULTS: Polycystic ovaries were found in 42% of women and were associated with hirsutism; previous hysterectomy; higher free testosterone, triglyceride, and C-peptide levels; and lower high-density lipoprotein cholesterol levels. Women with polycystic ovaries had more extensive coronary artery disease than women with normal ovaries (number of segments with > 50% stenosis, 1.7 [95% CI, 1.1 to 2.3] compared with 0.82 [CI, 0.54 to 1.1]; P < 0.01). On logistic regression analysis, the extent of coronary artery disease (P = 0.032) and family history of heart disease (P = 0.022) were predictors of the presence of polycystic ovaries.
CONCLUSIONS: In women having coronary angiography, those with more extensive coronary artery disease were more likely to have polycystic ovaries on ultrasonography than were those with less extensive disease. Visualization of polycystic ovaries by sonography was associated with distinct metabolic and endocrine abnormalities. Further study is required to evaluate whether surgery or hormone replacement therapy can modify the risk.

Entities:  

Mesh:

Year:  1997        PMID: 8992921     DOI: 10.7326/0003-4819-126-1-199701010-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  38 in total

Review 1.  Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.

Authors:  Kristen Farrell; Michael H Antoni
Journal:  Fertil Steril       Date:  2010-05-14       Impact factor: 7.329

Review 2.  Insulin resistance and polycystic ovary syndrome.

Authors:  David A Ehrmann
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

Review 3.  Polycystic ovarian syndrome: the metabolic syndrome comes to gynaecology.

Authors:  Z E Hopkinson; N Sattar; R Fleming; I A Greer
Journal:  BMJ       Date:  1998-08-01

Review 4.  New routes in the polycystic ovary syndrome labyrinth: a way out?

Authors:  P Moghetti; R Castello
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

Review 5.  Adverse Pregnancy Conditions, Infertility, and Future Cardiovascular Risk: Implications for Mother and Child.

Authors:  Ki Park; Janet Wei; Margo Minissian; C Noel Bairey Merz; Carl J Pepine
Journal:  Cardiovasc Drugs Ther       Date:  2015-08       Impact factor: 3.727

6.  Significance of plasma C-peptide in obese African American adolescents.

Authors:  Gregory V Williams; Kanwal K Gambhir; Gail Nunlee-Bland; Cynthia K Abrams; Vijaya Ganta; Wolali Odonkor
Journal:  J Natl Med Assoc       Date:  2011 Sep-Oct       Impact factor: 1.798

7.  Assessing the intersection of cardiovascular disease, venous thromboembolism, and polycystic ovary syndrome.

Authors:  Ekwutosi M Okoroh; Sheree L Boulet; Mary G George; W Craig Hooper
Journal:  Thromb Res       Date:  2015-10-17       Impact factor: 3.944

8.  Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease.

Authors:  Andrew J Krentz; Denise von Mühlen; Elizabeth Barrett-Connor
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

9.  The importance of speckle tracking echocardiography in the early detection of left ventricular dysfunction in patients with polycystic ovary syndrome.

Authors:  Selami Demirelli; Husnu Degirmenci; Emrah Ermis; Sinan Inci; Gokay Nar; Mehmet Emin Ayhan; Serdar Fırtına; Hikmet Hamur; Senay Arikan Durmaz
Journal:  Bosn J Basic Med Sci       Date:  2015-10-19       Impact factor: 3.363

10.  Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome.

Authors:  Abha Majumdar; Tejshree A Singh
Journal:  J Hum Reprod Sci       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.